Based on the cost–effectiveness threshold of £30,000 or $40,000 per QALY, antiviral therapies can be recommended for influenza treatment and post-exposure prevention in high-risk patients, the ...
As flu cases continue to rise globally, the demand for effective treatment options has surged. 2.Advancements in Antiviral Medications: The development of new antiviral drugs, such as baloxavir ...